PASITHEA THERAPEUTICS CORP. (KTTA) Operating cash flow 2021–2025
PASITHEA THERAPEUTICS CORP. (KTTA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$15.2MFY2025 · since FY2021: -$3.2M → -$15.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$15.2M | -9.3% |
| FY2024 | -$13.9M | -8.7% |
| FY2023 | -$12.8M | +12.0% |
| FY2022 | -$14.6M | -358.8% |
| FY2021 | -$3.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KTTA financial trends
KTTA RevenueKTTA Net incomeKTTA Net marginKTTA Gross profitKTTA Gross marginKTTA Operating incomeKTTA Operating marginKTTA Free cash flowKTTA Capital expendituresKTTA Return on equityKTTA Stock buybacksKTTA Dividends paidKTTA Total assetsKTTA Total liabilitiesKTTA Shareholders’ equityKTTA overview →